48 results
Page 2 of 3
8-K
EX-10.18
bd9rwfjfg0au9a35 pld
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.2
rd153npf4ac 80sb1v
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
qozo4qqy qn8blete
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
dcesatpsad
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
4hwo3fjaeac7pc
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-8.1
ysv wox41xlm
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.17
7dl npf6t5f5u7
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
vzpzi6cxz5fhm uze93
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
3br9jrk euoglgyrsla
18 Mar 21
Financial Statements and Exhibits
9:08am
10-K
t7cc6 3i6mol
5 Mar 21
Annual report
8:13am
8-K
EX-10.2
y4v855ag
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
8-K
EX-1.1
xrx4 xa4j
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
424B4
b3u7h0z4
9 Jul 20
Prospectus supplement with pricing info
4:46pm